Stage-specific TREM2 pathway targeting based on disease progression with biomarker-guided intervention timing
Curated pathway from expert analysis
flowchart TD
A["Disease Stage Assessment<br/>Plasma CSF Biomarker Panel"]
B["Early AD Stage<br/>Low Amyloid Tau Burden"]
C["Late AD Stage<br/>High Amyloid Tau Burden"]
D["TREM2 Agonist Treatment<br/>AL002c Anti-TREM2 Antibody"]
E["TREM2 Pathway Modulation<br/>TYROBP-SYK-PI3K Signaling"]
F["Microglial Phagocytosis Enhanced<br/>Amyloid Plaque Clearance"]
G["Anti-Inflammatory Phenotype<br/>DAM Homeostatic Balance"]
H["TREM2 Partial Antagonist<br/>Reduce Excessive Microglial Activation"]
I["Neuroprotection via Timing<br/>AD Progression Slowed"]
A --> B
A --> C
B --> D
C --> H
D --> E
E --> F
F --> G
H --> G
G --> I
style E fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
style I fill:#1b5e20,stroke:#a5d6a7,color:#a5d6a7No linked papers recorded for this hypothesis yet.
No curated PDB or AlphaFold mapping for ['TREM2' yet. Search RCSB →
No curated ClinVar variants loaded for this hypothesis.
Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.
No DepMap CRISPR Chronos data found for ['TREM2', 'TYROBP'].
Run python3 scripts/backfill_hypothesis_depmap.py to populate.
| Prediction | Predicted | Observed | Status | Conf |
|---|---|---|---|---|
| IF TREM2/TYROBP pathway agonism is administered to 5xFAD mice at early disease stage (characterized by low plasma soluble TREM2 and minimal plaque deposition), THEN microglial phagocytic activity will | Increased microglial clustering at amyloid plaques (CD68+IBA1+ co-localization >40% above baseline), 30% reduction in Thioflavin-S+ plaque area, and improved pe | — no observation — | pending | 0.75 |
| IF TREM2/TYROBP pathway agonism is administered to 5xFAD mice at late disease stage (characterized by high plasma soluble TREM2 and extensive plaque deposition), THEN neuroinflammatory markers (IL-1β, | No statistically significant improvement in spatial memory (Morris water maze latency difference <10% from vehicle), no reduction in IL-1β or TNF-α cortical lev | — no observation — | pending | 0.72 |